Insiders · Profile

Howton David T

Chief Operating Officer at Solid Biosciences · EVP, General Counsel at Sarepta Therapeutics · SVP at Vertex Pharmaceuticals. Filing since 1 Sep 2011. CIK 0001529297

Company
Date
Role
Action
Shares
Amount
Of holding
18 Feb 2026
Chief Operating Officer
Sold on a plan
7,469
$43.49K
6.6%
4 Feb 2026
Chief Operating Officer
Sold on a plan
18,894
$121.71K
16.2%
2 Feb 2026
Chief Operating Officer
Sold on a plan
37,771
$243.13K
24.4%
3 Dec 2025
Chief Operating Officer
Sold on a plan
4,932
$25.20K
13.0%
14 Feb 2025
Chief Operating Officer
Sold on a plan
5,561
$22.02K
18.3%
3 Dec 2024
Chief Operating Officer
Sold at will
5,072
$28.40K
24.5%
4 Dec 2023
Chief Operating Officer
Sold at will
5,367
$14.92K
41.1%
22 Jun 2020
EVP, General Counsel
Sold, plan not stated
105,122
$17.96M
76.7%
13 Dec 2019
EVP, General Counsel
Sold, plan not stated
78,000
$9.79M
75.6%
22 Nov 2019
EVP, General Counsel
Sold, plan not stated
25,000
$2.63M
67.6%
1 Feb 2019
SVP, General Counsel
Sold, plan not stated
30,000
$4.20M
60.5%
16 Jul 2018
SVP, General Counsel
Sold, plan not stated
50,000
$6.82M
58.9%
20 Jul 2017
SVP, General Counsel
Sold, plan not stated
25,000
$1.03M
52.9%
22 Sep 2016
SVP, General Counsel
Sold, plan not stated
7,000
$420.00K
24.6%
19 Sep 2016
SVP, General Counsel
Sold, plan not stated
9,304
$465.20K
74.6%
1 Sep 2011
SVP
Sold, plan not stated
328
$14.53K
3.4%
16 decisions on file.